We Are LC Sciences
- Headquarters in Houston, Texas – USA
- Offices in USA & China
- Representatives in Europe, Japan, Korea, & India
- Customers in > 40 countries
- First microRNA microarray service provider (since 2005)
- Leading position in customer publications in peer reviewed journals
What We Do
While some recent breakthrough discoveries have provided answers to long standing questions, others have raised even more basic biological questions. There still remains a vast need for understanding many significant pathologies at the genomic level. LC Sciences provides comprehensive services to the academic and biotech communities that are designed to be one-stop and produce the results needed to quickly advance our customers’ biological and biomedical research.
Development of novel clinical diagnostics and molecular medicines is key to fulfilling the promise of personalized medicine for treating cancer, heart disease, neurological disorders and other significant diseases. The identification of novel biomarkers based on disease-related genes, genetic mutations, and known genomes of infectious viruses and pathogens will require integrated technology platforms such as those developed at LC Sciences.
The study of key traits such as plant growth and development, stress response, hybrid vigor, and reproduction at the genomic level will be essential for agronomic advancement. Though new focus on agriculture has provided a large amount of new genomic information and tools, there still remains a challenge of working with non-model, highly varied species. LC Sciences’ innovative products and comprehensive services are based on in-house developed parallel-synthesis and targeted sequencing technologies that offer unprecedented flexibility and customization capability.
Our Latests Successes
- MicroRNAs Involved With Nephrotoxicity And Their Future Therapeutic Potential
- Genes to Improve Nitrogen and Phosphorus Utilization Efficiency in Chinese Fir
- MiRNAs May Serve as Potential Candidates for Hepatocellular Carcinoma Prognosis and Therapy
- Understanding the Function of miRNAs During Evolution
- Understanding the Mechanisms that Underlie Porcine Myofiber Development
- TRP3 Structure Found to be Related to Peptide’s Conformation in the Toroidal Pore
- miRNAs Bridging Viral Infection and Host Autophagy In Vivo